Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | OR51E2 | Q9H255 | 2/20 | 0.40 |
| ▸ | MMP1 | P03956 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | MMP3 | P08254 | 1/20 | 0.39 |
| ▸ | MMP9 | P14780 | 1/20 | 0.39 |
| ▸ | MMP13 | P45452 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.36 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.36 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.36 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.36 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.36 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.36 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Oxoisohexanoate SCHEMBL43491 | 1.00 | — | — | |
| 2-Oxoisohexanoate SCHEMBL6845538 | 0.97 | CA2 (0.50) | CA2ALDH1A1TDP1OR51E2MMP1 | |
| 2-Oxoisohexanoate SCHEMBL2224962 | 0.97 | CA2 (0.50) | CA2ALDH1A1TDP1OR51E2MMP1 | |
| 2-Oxoisohexanoate SCHEMBL4364799 | 0.97 | CA2 (0.50) | CA2ALDH1A1TDP1OR51E2MMP1 | |
| 2-Oxoisohexanoate SCHEMBL7278860 | 0.97 | CA2 (0.50) | CA2ALDH1A1TDP1OR51E2MMP1 | |
| 2-Oxoisohexanoate SCHEMBL5160502 | 0.94 | CA2 (0.48) | CA2ALDH1A1TDP1OR51E2MMP1 | |
| 2-Oxoisohexanoate SCHEMBL28052970 | 0.92 | ALDH1A1 (0.50) | CA2ALDH1A1TDP1OR51E2MMP1 | |
| 2-Oxoisohexanoate SCHEMBL31717986 | 0.89 | CA2 (0.44) | CA2ALDH1A1TDP1OR51E2MMP1 | |
| 2-Oxoisohexanoate SCHEMBL5606890 | 0.87 | SLC7A5 (0.44) | CA2ALDH1A1TDP1MMP1MMP2 | |
| 2-Oxoisohexanoate SCHEMBL5606991 | 0.87 | OR51E2 (0.48) | CA2ALDH1A1TDP1OR51E2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024242409-A1 | MUTANT POLYPEPTIDE AND METHOD FOR PRODUCING L-VALINE USING SAME | 씨제이제일제당 (주) | 2024-11-28 | — | — | WO | disclosed |
| CN-114569633-B | Intestinal selective chelators for the treatment and prevention of autism and related disorders | 轴向治疗公司 | 2023-11-17 | — | — | CN | disclosed |
| CN-114569633-A | Gut-selective chelating agents for the treatment and prevention of autism and related disorders | 轴向治疗公司 | 2022-06-03 | — | — | CN | disclosed |
| EP-3986432-A1 | OPTIMIZED BACTERIA ENGINEERED TO TREAT DISORDERS INVOLVING THE CATABOLISM OF LEUCINE, ISOLEUCINE, AND/OR VALINE | Synlogic Operating Company, Inc. (US) | 2022-04-27 | — | — | EP | disclosed |
| EP-3388524-B1 | ENZYMATIC METHOD FOR PRODUCING 2-HYDROXY-4-METHYLMERCAPTOBUTANOIC ACID (MHA) | EVONIK OPERATIONS GMBH (DE) | 2022-03-16 | — | — | EP | disclosed |
| CN-110944650-B | Gut-selective chelating agents for the treatment and prevention of autism and related disorders | 轴向治疗公司 | 2022-03-04 | — | — | CN | disclosed |
| CN-114085800-A | Novel isopropylmalate synthase variants and method for producing L-leucine using same | CJ第一制糖株式会社 | 2022-02-25 | — | — | CN | disclosed |
| CN-108884449-B | Novel isopropylmalate synthase variants and method for producing L-leucine using same | CJ第一制糖株式会社 | 2022-01-25 | — | — | CN | disclosed |
| WO-2020257610-A1 | OPTIMIZED BACTERIA ENGINEERED TO TREAT DISORDERS INVOLVING THE CATABOLISM OF LEUCINE, ISOLEUCINE, AND/OR VALINE | SYNLOGIC OPERATING COMPANY, INC. (US) | 2020-12-24 | — | — | WO | disclosed |
| EP-3307870-A1 | BACTERIA ENGINEERED TO TREAT DISORDERS INVOLVING THE CATABOLISM OF A BRANCHED CHAIN AMINO ACID | Synlogic, Inc. (US) | 2018-04-18 | — | — | EP | disclosed |
| WO-2016201380-A9 | BACTERIA ENGINEERED TO TREAT DISORDERS INVOLVING THE CATABOLISM OF A BRANCHED CHAIN AMINO ACID | SYNLOGIC, INC. (US) | 2017-02-16 | — | — | WO | disclosed |
| WO-2016201380-A1 | BACTERIA ENGINEERED TO TREAT DISORDERS INVOLVING THE CATABOLISM OF A BRANCHED CHAIN AMINO ACID | SYNLOGIC, INC. (US) | 2016-12-15 | — | — | WO | disclosed |